Fiala T G, Lee W P, May J W
Division of Plastic Surgery, Massachusetts General Hospital, Boston 02114.
Ann Plast Surg. 1993 Jun;30(6):503-9.
A detailed survey on aesthetic augmentation mammoplasty was sent to patients who had undergone this procedure at the Massachusetts General Hospital between July 1973 and July 1991 to determine the incidence of postoperative complications after augmentation mammoplasty, and to qualify the factors related to patient satisfaction (n = 304). Surgical records of respondents were examined. After a mean follow-up of 8.2 years, there were no patients with known breast cancer or autoimmune disease after augmentation. Five implants (2.5%) were replaced due to leakage. Other complications were rare. Overall satisfaction was high and correlated inversely with capsular contracture ratings and elapsed time. Contracture ratings increased with time for silicone implants. Gel implants in the submuscular position were softer than subglandular ones after 5 years elapsed time. Most women are satisfied after augmentation mammoplasty, despite a significant incidence of capsular contracture. The incidence of other adverse effects after augmentation is low. Augmentation mammoplasty does not appear to be an inducer of autoimmune disease or of breast cancer.
一项关于美容隆胸手术的详细调查被发送给了1973年7月至1991年7月期间在马萨诸塞州总医院接受该手术的患者,以确定隆胸手术后并发症的发生率,并确定与患者满意度相关的因素(n = 304)。对受访者的手术记录进行了检查。平均随访8.2年后,隆胸后没有已知患有乳腺癌或自身免疫性疾病的患者。因渗漏更换了5个植入物(2.5%)。其他并发症很少见。总体满意度较高,且与包膜挛缩评级和时间呈负相关。硅胶植入物的挛缩评级随时间增加。放置5年后,肌下位置的凝胶植入物比腺下植入物更柔软。尽管包膜挛缩的发生率较高,但大多数女性在隆胸后仍感到满意。隆胸后其他不良反应的发生率较低。隆胸手术似乎不是自身免疫性疾病或乳腺癌的诱发因素。